Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Bladder cancer
Treatment/Intervention:  complementary or alternative medicine procedure
Trial Status:  Active
Results 1-7 of 7 for your search:
Start Over
Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000602239, UZG-CUL-UHG-Non-InvasiveBladde, EU-20870, UZG-CUL-UHG-Non-InvasiveBladderCancer, CUL-UHG-Non-Invasive Bladder Cancer, NCT00729287
Managing Cancer and Living Meaningfully (CALM): A Study to Evaluate the Effectiveness of a Psychological Intervention for Cancer Patients
Phase: Phase III
Type: Educational/Counseling/Training, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UHN REB 09-0855-C, CIHR, NCT01506492
Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment
Phase: Phase II
Type: Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: IRB00050273, NCT01489813
Short-Term Fasting: Impact on Toxicity
Phase: No phase specified
Type: Supportive care
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 0S-08-9, NCT00936364
Improving Sensitivity of Urine Cytology for Bladder Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Active
Age: Over 18 to 80
Sponsor: Other
Protocol IDs: J1236, NCT01826097
Prehabilitation to Enhance Postoperative Functional Capacity Following Radical Cystectomy
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: 12-454-SDR, NCT01836978
EGCG Modulate the Cytotoxic Effects of Chemotherapeutic Agents in Human Urothelial Carcinoma Cells
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Approved-not yet active
Age: 20 to 80
Sponsor: Other
Protocol IDs: 201308047RIN, 103-002509, NCT01993966
Start Over